Page last updated: 2024-08-25

rebeccamycin and Carcinoma, Oat Cell

rebeccamycin has been researched along with Carcinoma, Oat Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dowlati, A; Fu, P; Halmos, B; Ivy, P; Ma, PC; Mekhail, T; O'Brien, T; Schwandt, A	1

Trials

1 trial(s) available for rebeccamycin and Carcinoma, Oat Cell

Article	Year
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	2012

Article

Year

Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:4

Topics: Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2012